CN113816991B - 一种氯化磷酸胆碱钙的制备方法 - Google Patents
一种氯化磷酸胆碱钙的制备方法 Download PDFInfo
- Publication number
- CN113816991B CN113816991B CN202111206605.2A CN202111206605A CN113816991B CN 113816991 B CN113816991 B CN 113816991B CN 202111206605 A CN202111206605 A CN 202111206605A CN 113816991 B CN113816991 B CN 113816991B
- Authority
- CN
- China
- Prior art keywords
- calcium chloride
- choline
- chloride
- dioxaphospholane
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960001231 choline Drugs 0.000 title claims abstract description 12
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- YLOZVEBTKJNEIS-UHFFFAOYSA-L calcium;dihydrogen phosphate;chloride Chemical compound Cl.[Ca+2].OP([O-])([O-])=O YLOZVEBTKJNEIS-UHFFFAOYSA-L 0.000 title claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 45
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims abstract description 28
- SBMUNILHNJLMBF-UHFFFAOYSA-N 2-chloro-1,3,2$l^{5}-dioxaphospholane 2-oxide Chemical compound ClP1(=O)OCCO1 SBMUNILHNJLMBF-UHFFFAOYSA-N 0.000 claims abstract description 21
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims abstract description 20
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 14
- 239000001110 calcium chloride Substances 0.000 claims abstract description 14
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- VJRYWXNPDKUNNG-UHFFFAOYSA-N 1,3,2lambda5-dioxaphospholane 2-oxide Chemical compound O=P1OCCO1 VJRYWXNPDKUNNG-UHFFFAOYSA-N 0.000 claims 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N methyl ethyl ketone Substances CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 1
- 229940032007 methylethyl ketone Drugs 0.000 claims 1
- BJAARRARQJZURR-UHFFFAOYSA-N trimethylazanium;hydroxide Chemical compound O.CN(C)C BJAARRARQJZURR-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 24
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 abstract description 12
- 235000019743 Choline chloride Nutrition 0.000 abstract description 12
- 229960003178 choline chloride Drugs 0.000 abstract description 12
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 abstract description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 6
- 239000011575 calcium Substances 0.000 abstract description 6
- 229910052791 calcium Inorganic materials 0.000 abstract description 6
- 229910019142 PO4 Inorganic materials 0.000 abstract description 2
- 239000012535 impurity Substances 0.000 abstract description 2
- 239000010452 phosphate Substances 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- OGPMUTIEFPDJAX-UHFFFAOYSA-M calcium;2-(trimethylazaniumyl)ethyl phosphate Chemical compound [Ca+2].C[N+](C)(C)CCOP([O-])([O-])=O OGPMUTIEFPDJAX-UHFFFAOYSA-M 0.000 description 8
- 239000000203 mixture Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 5
- ICVPTJCCKTXCDT-UHFFFAOYSA-L calcium;2-(trimethylazaniumyl)ethyl phosphate;chloride Chemical compound [Cl-].[Ca+2].C[N+](C)(C)CCOP([O-])([O-])=O ICVPTJCCKTXCDT-UHFFFAOYSA-L 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000010533 azeotropic distillation Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000000865 phosphorylative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QAIRZQBZKJPMHC-UHFFFAOYSA-J 2-hydroxyethyl(trimethyl)azanium phosphonato phosphate Chemical compound C[N+](C)(C)CCO.C[N+](C)(C)CCO.C[N+](C)(C)CCO.C[N+](C)(C)CCO.[O-]P([O-])(=O)OP([O-])([O-])=O QAIRZQBZKJPMHC-UHFFFAOYSA-J 0.000 description 1
- AZRZBCASYOBNKQ-UHFFFAOYSA-N 6-chloro-3,5-diaminopyrazine-3-carboxamide Chemical compound CN(C)C(N)=NC(=O)C1=NC(Cl)=C(N)N=C1N AZRZBCASYOBNKQ-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- -1 phosphoryl choline calcium chlorideSalt Chemical class 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/106—Adducts, complexes, salts of phosphatides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111206605.2A CN113816991B (zh) | 2021-10-17 | 2021-10-17 | 一种氯化磷酸胆碱钙的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111206605.2A CN113816991B (zh) | 2021-10-17 | 2021-10-17 | 一种氯化磷酸胆碱钙的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113816991A CN113816991A (zh) | 2021-12-21 |
CN113816991B true CN113816991B (zh) | 2023-12-15 |
Family
ID=78920380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111206605.2A Active CN113816991B (zh) | 2021-10-17 | 2021-10-17 | 一种氯化磷酸胆碱钙的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113816991B (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102584891A (zh) * | 2012-01-13 | 2012-07-18 | 太仓市茜泾化工有限公司 | 一种氯化磷酰胆碱钙盐的制备方法 |
CN103193819A (zh) * | 2013-03-13 | 2013-07-10 | 苏州蔻美新材料有限公司 | 一锅法合成mpc的方法 |
CN103421039A (zh) * | 2013-09-03 | 2013-12-04 | 重庆工商大学 | 2-甲基丙烯酰氧基乙基磷酰胆碱的合成方法 |
CN103694271A (zh) * | 2013-12-02 | 2014-04-02 | 常熟富士莱医药化工有限公司 | 氯化磷酰胆碱钙盐的制备方法 |
CN104212432A (zh) * | 2013-06-04 | 2014-12-17 | 中国石油化工股份有限公司 | 阴-阳离子型双子表面活性剂及其制备方法 |
WO2017201076A1 (en) * | 2016-05-16 | 2017-11-23 | The Board Of Regents Of The University Of Texas System | Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids |
KR20180041398A (ko) * | 2016-10-14 | 2018-04-24 | 에스디코리아(주) | 비할로겐 인계 난연제 제조방법 |
CN110590848A (zh) * | 2019-09-10 | 2019-12-20 | 恒大新能源科技集团有限公司 | 阻燃添加剂及其制备方法和应用 |
CN111217856A (zh) * | 2020-01-22 | 2020-06-02 | 恒大新能源技术(深圳)有限公司 | 五元环磷酸酯类化合物及其制备方法和应用 |
-
2021
- 2021-10-17 CN CN202111206605.2A patent/CN113816991B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102584891A (zh) * | 2012-01-13 | 2012-07-18 | 太仓市茜泾化工有限公司 | 一种氯化磷酰胆碱钙盐的制备方法 |
CN103193819A (zh) * | 2013-03-13 | 2013-07-10 | 苏州蔻美新材料有限公司 | 一锅法合成mpc的方法 |
CN104212432A (zh) * | 2013-06-04 | 2014-12-17 | 中国石油化工股份有限公司 | 阴-阳离子型双子表面活性剂及其制备方法 |
CN103421039A (zh) * | 2013-09-03 | 2013-12-04 | 重庆工商大学 | 2-甲基丙烯酰氧基乙基磷酰胆碱的合成方法 |
CN103694271A (zh) * | 2013-12-02 | 2014-04-02 | 常熟富士莱医药化工有限公司 | 氯化磷酰胆碱钙盐的制备方法 |
WO2017201076A1 (en) * | 2016-05-16 | 2017-11-23 | The Board Of Regents Of The University Of Texas System | Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids |
CN109414408A (zh) * | 2016-05-16 | 2019-03-01 | 得克萨斯州大学系统董事会 | 阳离子磺酰胺氨基脂质和两亲性两性离子氨基脂质 |
KR20180041398A (ko) * | 2016-10-14 | 2018-04-24 | 에스디코리아(주) | 비할로겐 인계 난연제 제조방법 |
CN110590848A (zh) * | 2019-09-10 | 2019-12-20 | 恒大新能源科技集团有限公司 | 阻燃添加剂及其制备方法和应用 |
CN111217856A (zh) * | 2020-01-22 | 2020-06-02 | 恒大新能源技术(深圳)有限公司 | 五元环磷酸酯类化合物及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
"Silicon-phosphorus analogies. Rate-controlling factors in SN2(P) reactions. Influence of the nucleophile for a given stereochemistry";Robert J.P. Corriu等;《Tetrahedron Letters》;第24卷(第40期);第4323-4326页 * |
尹志刚 主编 .《有机磷化合物》.北京:化学工业出版社,2011,(第1版),第189-190,196-197页. * |
Also Published As
Publication number | Publication date |
---|---|
CN113816991A (zh) | 2021-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109694388B (zh) | 一种含磷化合物及其制备方法、用途 | |
CN103665032B (zh) | 一种草铵膦的制备方法 | |
EP0262227B1 (en) | Process for the preparation of myoinositol derivatives | |
CN113816991B (zh) | 一种氯化磷酸胆碱钙的制备方法 | |
WO2022242540A1 (zh) | 一种三配位磷衍生物及中间体及制备方法 | |
KR100951108B1 (ko) | 라세믹 또는 광학적으로 활성이 있는 α-글리세로포스포릴콜린 및 그 유도체의 제조방법 | |
KR101249361B1 (ko) | 고순도 트리스(트리알킬실릴)포스파이트의 제조 방법 | |
CN109694387B (zh) | 一种含磷化合物及其制备方法、用途 | |
CN112500433A (zh) | 一种磷酸特地唑胺的制备方法 | |
CN110642885A (zh) | 一种多取代苯酚磷酸酯盐及其制备方法和应用 | |
JPH03181493A (ja) | 純粋な環状リン酸ジアリールエステルの製造方法 | |
CN114249786A (zh) | 含n,n-二酰基结构核苷中间体的制备和应用 | |
JP3901321B2 (ja) | リボフラビン−5’−リン酸またはそのナトリウム塩の製造法 | |
IE912920A1 (en) | Process for the preparation of aminomethylphosphonic acid¹and aminomethylphosphinic acids | |
CN109627262A (zh) | 对甲苯磺酰氧甲基亚甲基二膦酸四乙酯及其制备方法、泰诺福韦的杂质及其制备方法 | |
JP4511368B2 (ja) | ホスホロジアミダイト生産方法 | |
JP2023086184A (ja) | リン酸エステル化合物の製造方法 | |
CN113402547B (zh) | 一种n-酰基磷酰胺类化合物的合成方法 | |
CN114409706B (zh) | 一种苯基氢膦酸酯及其中间体的制备方法 | |
CN109096331B (zh) | 一种制备邻二芳基磷酰基取代酚类衍生物的方法 | |
CN110627830A (zh) | 对硝基苯磷酸二钠及其制备方法 | |
US6215013B1 (en) | Preparation of phosphonic acid derivatives | |
Guervenou et al. | Phthalimide derivatives towards phosphorylated reactants: Unexpected, but interesting, reactions | |
EP1675863A2 (en) | Method for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof | |
SU653264A1 (ru) | Способ получени неполных эфиров фосфорзамещенной метилфосфонистой кислоты |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 453002 No.398 Jingquan West Road, high tech Zone, Xinxiang City, Henan Province Applicant after: Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Applicant after: XINXIANG PHARMACEUTICAL CO.,LTD. Address before: 453002 No.398 Jingquan West Road, high tech Zone, Xinxiang City, Henan Province Applicant before: XINXIANG TUOXIN PHARMACEUTICAL CO.,LTD. Applicant before: XINXIANG PHARMACEUTICAL CO.,LTD. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20231114 Address after: No. 515 Kelong Avenue, Gaoxin District, Xinxiang City, Henan Province, 453002 Applicant after: Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Applicant after: XINXIANG PHARMACEUTICAL CO.,LTD. Applicant after: Henan Dingxin Pharmaceutical Technology Co.,Ltd. Address before: 453002 No.398 Jingquan West Road, high tech Zone, Xinxiang City, Henan Province Applicant before: Xinxiang Tuoxin Pharmaceutical Co.,Ltd. Applicant before: XINXIANG PHARMACEUTICAL CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |